Resection for intrahepatic cholangiocellular cancer: new advances

Imagem de Miniatura
Arquivos
art_WAISBERG_Resection_for_intrahepatic_cholangiocellular_cancer_new_advances_2018.PDF (536.78 KB)
Citações na Scopus
30
Tipo de produção
article
Data de publicação
2018
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
AME PUBL CO
Autores
LAI, Quirino
Citação
TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, v.3, article ID 60, 13p, 2018
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Intrahepatic cholangiocarcinoma (ICC) is the second most prevalent primary liver neoplasm after hepatocellular carcinoma (HCC), corresponding to 10% to 15% of cases. Pathologies that cause chronic biliary inflammation and bile stasis are known predisposing factors for development of ICC. The incidence and cancer-related mortality of ICC is increasing worldwide. Most patients remain asymptomatic until advance stage, commonly presenting with a liver mass incidentally diagnosed. The only potentially curative treatment available for ICC is surgical resection. The prognosis is dismal for unresectable cases. The principle of the surgical approach is a margin negative hepatic resection with preservation of adequate liver remnant. Regional lymphadenectomy is recommended at time of hepatectomy due to the massive impact on outcomes caused by lymph node (LN) metastasis. Multicentric disease, tumor size, margin status and tumor differentiation are also important prognostic factors. Staging laparoscopy is warranted in high-risk patients to avoid unnecessary laparotomy. Exceedingly complex surgical procedures, such as major vascular, extrahepatic bile ducts and visceral resections, ex vivo hepatectomy and autotransplantation, should be implemented in properly selected patients to achieve negative margins. Neoadjuvant therapy may be used in initially unresectable lesions in order to downstage and allow resection. Despite optimal surgical management, recurrence is frustratingly high. Adjuvant chemotherapy with radiation associated with locoregional treatments should be considered in cases with unfavorable prognostic factors. Selected patients may undergo re-resection of tumor recurrence. Despite the historically poor outcomes of liver transplantation for ICC, highly selected patients with unresectable disease, especially those with adequate response to neoadjuvant therapy, may be offered transplant. In this article, we reviewed the current literature in order to highlight the most recent advances and recommendations for the surgical treatment of this aggressive malignancy.
Palavras-chave
Cholangiocarcinoma, biliary tract cancer, intrahepatic, surgery, resection, liver transplantation
URI
https://observatorio.fm.usp.br/handle/OPI/29469
Referências
  1. Abu Hilal M, 2011, J LAPAROENDOSC ADV S, V21, P845, DOI 10.1089/lap.2011.0247
  2. Ali SM, 2013, ANN SURG ONCOL, V20, P2023, DOI 10.1245/s10434-012-2808-2
  3. Aljiffry M, 2009, J AM COLL SURGEONS, V208, P134, DOI 10.1016/j.jamcollsurg.2008.09.007
  4. Aloia TA, 2015, JAMA SURG, V150, P927, DOI 10.1001/jamasurg.2015.1646
  5. Amin MB, 2017, AJCC CANC STAGING MA
  6. Amini N, 2014, J GASTROINTEST SURG, V18, P2136, DOI 10.1007/s11605-014-2667-1
  7. Anderson CD, 2004, J GASTROINTEST SURG, V8, P90, DOI 10.1016/j.gausser.2003.10.003
  8. Bagante F, 2018, HPB OXFORD
  9. Bagante F, 2018, WORLD J SURG, V42, P2551, DOI 10.1007/s00268-017-4453-1
  10. Bagante F, 2017, ANN SURG ONCOL, V24, P2491, DOI 10.1245/s10434-017-5870-y
  11. Baker MA, 2015, J GASTROINTEST SURG, V19, P1169, DOI 10.1007/s11605-015-2806-3
  12. Baron TH, 2004, CLIN GASTROENTEROL H, V2, P214, DOI 10.1053/S1542-3565(04)00006-0
  13. Bartsch F, 2018, INT J SURG, V55, P193, DOI 10.1016/j.ijsu.2018.05.027
  14. Brandsaeter B, 2004, J HEPATOL, V40, P815, DOI 10.1016/j.jhep.2004.01.002
  15. Brauer DG, 2018, HPB, V20, P470, DOI 10.1016/j.hpb.2017.11.010
  16. Buettner S, 2017, ONCOTARGETS THER, V10, P1131, DOI 10.2147/OTT.S93629
  17. Bupathi M, 2017, HEPATOL SURG NUTR, V6, P91, DOI 10.21037/hbsn.2016.12.12
  18. Chong YS, 2012, CLIN RADIOL, V67, P766, DOI 10.1016/j.crad.2012.01.004
  19. Corvera CU, 2008, J AM COLL SURGEONS, V206, P57, DOI 10.1016/j.jamcollsurg.2007.07.002
  20. D'Angelica M, 2003, ANN SURG ONCOL, V10, P183, DOI 10.1245/ASO.2003.03.091
  21. de Jong MC, 2011, J CLIN ONCOL, V29, P3140, DOI 10.1200/JCO.2011.35.6519
  22. Dodson RM, 2013, J AM COLL SURGEONS, V217, P736, DOI 10.1016/j.jamcollsurg.2013.05.021
  23. Doussot A, 2016, J AM COLL SURGEONS, V223, P493, DOI 10.1016/j.jamcollsurg.2016.05.019
  24. Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4
  25. Endo I, 2008, ANN SURG, V248, P84, DOI 10.1097/SLA.0b013e318176c4d3
  26. Farges O, 2011, ANN SURG, V254, P824, DOI 10.1097/SLA.0b013e318236c21d
  27. Goere D, 2006, SURG ENDOSC, V20, P721, DOI 10.1007/s00464-005-0583-x
  28. GOLDSTEIN RM, 1993, AM J SURG, V166, P768, DOI 10.1016/S0002-9610(05)80696-8
  29. Goss JA, 1997, ANN SURG, V225, P472, DOI 10.1097/00000658-199705000-00004
  30. Herman Paulo, 2015, J Gastrointest Cancer, V46, P190, DOI 10.1007/s12029-015-9691-6
  31. Hong JC, 2011, ARCH SURG-CHICAGO, V146, P683, DOI 10.1001/archsurg.2011.116
  32. Horgan AM, 2012, J CLIN ONCOL, V30, P1934, DOI 10.1200/JCO.2011.40.5381
  33. Hyder O, 2013, SURGERY, V153, P811, DOI 10.1016/j.surg.2012.12.005
  34. Jia AY, 2015, J GASTROINTEST ONCOL, V6, P126, DOI 10.3978/j.issn.2078-6891.2014.102
  35. Kato A, 2015, ANN SURG ONCOL, V22, pS1093, DOI 10.1245/s10434-015-4768-9
  36. Kim YJ, 2003, EUR J NUCL MED MOL I, V30, P1467, DOI 10.1007/s00259-003-1297-8
  37. Kipp BR, 2004, AM J GASTROENTEROL, V99, P1675, DOI 10.1111/j.1572-0241.2004.30281.x
  38. Le Roy B, 2018, BRIT J SURG, V105, P839, DOI 10.1002/bjs.10641
  39. Lee W, 2016, SURG ENDOSC, V30, P4835, DOI 10.1007/s00464-016-4817-x
  40. Lopez-Lopez Victor, 2018, Oncotarget, V9, P28267, DOI 10.18632/oncotarget.25538
  41. Lunsford KE, 2018, LANCET GASTROENTEROL, V3, P337, DOI 10.1016/S2468-1253(18)30045-1
  42. Luo XW, 2014, J GASTROINTEST SURG, V18, P562, DOI 10.1007/s11605-013-2447-3
  43. Maithel SK, 2013, CANCER-AM CANCER SOC, V119, P3929, DOI 10.1002/cncr.28312
  44. Mavros MN, 2014, JAMA SURG, V149, P565, DOI 10.1001/jamasurg.2013.5137
  45. Meyer CG, 2000, TRANSPLANTATION, V69, P1633
  46. Mosconi S, 2009, CRIT REV ONCOL HEMAT, V69, P259, DOI 10.1016/j.critrevonc.2008.09.008
  47. Nagino M, 2006, ANN SURG, V243, P364, DOI 10.1097/01.sla.0000201482.11876.14
  48. Nakagawa T, 2005, WORLD J SURG, V29, P728, DOI 10.1007/s00268-005-7761-9
  49. Nakanuma Y, 2010, WORLD J HEPATOL, V2, P419, DOI 10.4254/wjh.v2.i12.419
  50. Orimo T, 2018, J GASTROENTEROL
  51. Palmer WC, 2012, J HEPATOL, V57, P69, DOI 10.1016/j.jhep.2012.02.022
  52. PICHLMAYR R, 1995, WORLD J SURG, V19, P807, DOI 10.1007/BF00299775
  53. Ratti F, 2015, UPDATES SURG, V67, P157, DOI 10.1007/s13304-015-0312-5
  54. Rayar M, 2015, ANN SURG ONCOL, V22, P3102, DOI 10.1245/s10434-014-4365-3
  55. Reames BN, 2017, HPB, V19, P901, DOI 10.1016/j.hpb.2017.06.008
  56. Reames BN, 2017, J SURG ONCOL, V116, P133, DOI 10.1002/jso.24633
  57. Ribero D, 2012, ARCH SURG-CHICAGO, V147, P1107, DOI 10.1001/archsurg.2012.1962
  58. Robles R, 2004, ANN SURG, V239, P265, DOI 10.1097/01.sla.0000108702.45715.81
  59. Robles R, 2012, EJSO-EUR J SURG ONC, V38, P586, DOI 10.1016/j.ejso.2012.03.007
  60. Sandri GBL, 2017, EJSO-EUR J SURG ONC, V43, P1617, DOI 10.1016/j.ejso.2017.02.012
  61. Sapisochin G, 2016, HEPATOLOGY, V64, P1178, DOI 10.1002/hep.28744
  62. Shaib YH, 2004, J HEPATOL, V40, P472, DOI 10.1016/j.jhep.2003.11.030
  63. Shimada K, 2009, SURGERY, V145, P411, DOI 10.1016/j.surg.2008.11.010
  64. Shindoh J, 2013, J AM COLL SURGEONS, V217, P126, DOI 10.1016/j.jamcollsurg.2013.03.004
  65. Song S, 2015, CLIN TRANSL ONCOL, V17, P825, DOI 10.1007/s12094-015-1312-0
  66. Spolverato G, 2016, ANN SURG ONCOL, V23, P235, DOI 10.1245/s10434-015-4642-9
  67. Spolverato G, 2015, ANN SURG ONCOL, V22, P4020, DOI 10.1245/s10434-015-4472-9
  68. Spolverato G, 2015, ANN SURG ONCOL, V22, P2218, DOI 10.1245/s10434-014-4223-3
  69. Squires MH, 2018, EXPERT REV GASTROENT, V12, P671, DOI 10.1080/17474124.2018.1489229
  70. Sulpice L, 2013, J SURG RES, V180, P56, DOI 10.1016/j.jss.2012.10.051
  71. Tamandl D, 2008, ANN SURG ONCOL, V15, P2787, DOI 10.1245/s10434-008-0081-1
  72. Tanaka K, 2015, EJSO-EUR J SURG ONC, V41, P506, DOI 10.1016/j.ejso.2015.01.031
  73. Tarchi P, 2018, SURGERY, V163, P698, DOI 10.1016/j.surg.2017.09.058
  74. Thirunavukarasu P, 2016, SURG CLIN N AM, V96, P197, DOI 10.1016/j.suc.2015.11.001
  75. Vicente E, 2017, ANN SURG ONCOL, V24, P3990, DOI 10.1245/s10434-017-6104-z
  76. Vitale A, 2016, J SURG ONCOL, V113, P685, DOI 10.1002/jso.24213
  77. Wang K, 2017, HEPATOBIL SURG NUTR, V6, P79, DOI 10.21037/hbsn.2017.01.06
  78. Wang YZ, 2013, J CLIN ONCOL, V31, P1188, DOI 10.1200/JCO.2012.41.5984
  79. Weber SM, 2015, HPB, V17, P669, DOI 10.1111/hpb.12441
  80. Yamasaki Susumu, 2003, J Hepatobiliary Pancreat Surg, V10, P288, DOI 10.1007/s00534-002-0732-8
  81. Yoh T, 2018, WORLD J SURG, V42, P1848, DOI 10.1007/s00268-017-4387-7
  82. Yoh T, 2018, J HEPATO-BIL-PAN SCI, V25, P299, DOI 10.1002/jhbp.552
  83. Zhang XF, 2018, BRIT J SURG, V105, P848, DOI 10.1002/bjs.10676
  84. Zhang XF, 2018, BRIT J SURG, V105, P857, DOI 10.1002/bjs.10827
  85. Zhang XF, 2018, SURGERY, V163, P1114, DOI 10.1016/j.surg.2018.01.001
  86. Zhang XF, 2018, J GASTROINTEST SURG, V22, P668, DOI 10.1007/s11605-017-3652-2

Coleções
Artigos e Materiais de Revistas Científicas - FM/MGT
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/37
Artigos e Materiais de Revistas Científicas - ODS/03